Eli Lilly has agreed to acquire Kelonia Therapeutics for up to $7 billion, in a deal that would bolster the buyer’s oncology pipeline with KLN-1010, a lentiviral in vivo CAR T therapy under study in ...

Researchers engineered a panel of drug-resistant NSCLC models using CRISPR gene editing and gene overexpression techniques.

Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...

Researchers suggest tunneling may reflect a conserved strategy adopted by specialized migratory cell types in dense tissues.

AACR chairs Paul Mischel and Alice Shaw shared insights with GEN on the key themes shaping this year’s program.

Using sensors and a light-activated drug, the team mapped neural pathways used by endogenous opioids to send pain relief ...

New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...

The customizable platform used AAVs to deliver genetic cargo that induced the production of three anti-inflammatory cytokines ...

Harnessing technology transferred from VTT Technical Research Centre of Finland, Proteins.1 is developing a PCR-like ...

Gene‑edited HPSCs programmed to make therapeutic antibodies and proteins show long‑lasting, boostable immunity in mouse models.

Researchers say knowing that semaglutide improves liver health independently of weight loss could influence prescribing decisions.

AWS's new AI platform grants researchers direct access to a broad library of biological foundation models for lab-in-the-loop drug discovery.